Salivary cortisol levels in persons with and without different anxiety disorders
- PMID: 20190128
- DOI: 10.1097/PSY.0b013e3181d2f0c8
Salivary cortisol levels in persons with and without different anxiety disorders
Abstract
Objective: To examine the association between several subtypes of anxiety disorders and various cortisol indicators in a large cohort study. Anxiety disorders have been suggested to be linked to hypothalamic-pituitary-adrenal (HPA) axis activity, although results are scarce and inconsistent. No earlier studies have examined consistency of HPA axis findings across several anxiety subtypes and whether associations are state or trait dependent.
Methods: Data are derived from 1427 participants of the Netherlands Study of Depression and Anxiety. Three groups were compared: 342 control participants without psychiatric disorders; 311 persons with a remitted (no current) anxiety disorder (social phobia, generalized anxiety disorder, panic disorder); and 774 persons with a current anxiety disorder, as diagnosed using the Composite International Diagnostic Interview psychiatric interview. Cortisol levels were measured in seven saliva samples, determining the 1-hour cortisol awakening response, evening cortisol, and cortisol response after 0.5 mg of dexamethasone ingestion.
Results: Current anxiety disorder was associated with higher awakening cortisol levels (p = .002). These findings were mainly present for patients with panic disorder with agoraphobia and anxious patients with comorbid depressive disorder. Remitted anxiety only showed a trend toward higher morning cortisol (p = .08). No associations were observed for anxiety status and evening cortisol level or cortisol suppression after dexamethasone.
Conclusions: This study showed a modest but significantly higher 1-hour cortisol awakening response among anxiety patients, which was driven by those with panic disorder with agoraphobia and those with comorbid depression.
Similar articles
-
Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.Arch Gen Psychiatry. 2009 Jun;66(6):617-26. doi: 10.1001/archgenpsychiatry.2009.50. Arch Gen Psychiatry. 2009. PMID: 19487626
-
Salivary cortisol levels and the 2-year course of depressive and anxiety disorders.Psychoneuroendocrinology. 2013 Sep;38(9):1494-502. doi: 10.1016/j.psyneuen.2012.12.017. Epub 2013 Jan 11. Psychoneuroendocrinology. 2013. PMID: 23313277
-
Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes.J Affect Disord. 2008 Mar;106(3):307-13. doi: 10.1016/j.jad.2007.07.025. Epub 2007 Aug 28. J Affect Disord. 2008. PMID: 17727959
-
HPA axis activity in patients with panic disorder: review and synthesis of four studies.Depress Anxiety. 2007;24(1):66-76. doi: 10.1002/da.20220. Depress Anxiety. 2007. PMID: 16845643 Review.
-
The differential diagnosis of anxiety. Psychiatric and medical disorders.Psychiatr Clin North Am. 1985 Mar;8(1):3-23. Psychiatr Clin North Am. 1985. PMID: 3887337 Review.
Cited by
-
In Vitro Assessment of Cortisol Release Inhibition, Bioaccessibility and Bioavailability of a Chemically Characterized Scutellaria lateriflora L. Hydroethanolic Extract.Molecules. 2024 Jan 25;29(3):586. doi: 10.3390/molecules29030586. Molecules. 2024. PMID: 38338331 Free PMC article.
-
Diurnal Salivary Cortisol in Relation to Body Composition and Heart Rate Variability in Young Adults.Front Endocrinol (Lausanne). 2022 Mar 9;13:831831. doi: 10.3389/fendo.2022.831831. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35355570 Free PMC article.
-
Doll therapy intervention for women with dementia living in nursing homes: a randomized single-blind controlled trial protocol.Trials. 2020 Feb 3;21(1):133. doi: 10.1186/s13063-020-4050-8. Trials. 2020. PMID: 32014029 Free PMC article. Clinical Trial.
-
A Review of Selected Studies That Determine the Physical and Chemical Properties of Saliva in the Field of Dental Treatment.Biomed Res Int. 2018 May 9;2018:6572381. doi: 10.1155/2018/6572381. eCollection 2018. Biomed Res Int. 2018. PMID: 29854777 Free PMC article. Review.
-
Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modifications.PLoS One. 2014 Apr 1;9(4):e91455. doi: 10.1371/journal.pone.0091455. eCollection 2014. PLoS One. 2014. PMID: 24690945 Free PMC article.